spironolactone has been researched along with ethinyl estradiol in 61 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (24.59) | 18.7374 |
| 1990's | 6 (9.84) | 18.2507 |
| 2000's | 19 (31.15) | 29.6817 |
| 2010's | 20 (32.79) | 24.3611 |
| 2020's | 1 (1.64) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Ernst, B; Lill, MA; Vedani, A; Winiger, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Azadian-Boulanger, G; Bonne, C; Bouton, MM; Moguilewsky, M; Philibert, D; Raynaud, JP | 1 |
| Challiner, MR; Park, BK; Whittaker, AD | 1 |
| Ali, A; Bassaw, B; Maharaj, R; Roopnarinesingh, S | 1 |
| Applebaum-Bowden, D; Demers, LM; Lenker, R; Wild, RA | 1 |
| Biffignandi, P; Molinatti, GM | 1 |
| Gordon, ER; Smith, DJ | 1 |
| Board, JA; Rosenberg, SM; Smeltzer, JS | 1 |
| Djøseland, O; Lunde, O | 1 |
| Kirschner, MA; Samojlik, E; Szmal, E | 1 |
| Moore, DC | 1 |
| Ahuja, MM; Buckshee, K | 1 |
| Chapman, MG; Dewhurst, CJ; Dowsett, M; Jeffcoate, SL | 1 |
| Dölle, W; Goebell, H | 1 |
| Chiou, WL; Smith, LD | 1 |
| Hammerstein, J; Moltz, L; Schwartz, U | 1 |
| Ylöstalo, P | 1 |
| Chaudhuri, N; Ghose, D; Kundu, D; Mitra, K; Mondal, S | 1 |
| Durmuşoğlu, F; Erenus, M; Gürbüz, O; Pekin, S; Yücelten, D | 1 |
| Wilson, L; Zemtsov, A | 1 |
| Keleştimur, F; Sahin, Y | 2 |
| Asscheman, H; Hage, JJ; Kanhai, RC; Mulder, JW | 1 |
| Lhullier, F; Lisboa, KO; Mattiello, S; Spritzer, PM | 1 |
| Bakas, P; Creatsas, G; Gregoriou, O; Konidaris, S; Mathiopoulos, D; Papadias, K | 1 |
| Kelestimur, F | 1 |
| Chen, W; Thiboutot, D | 1 |
| Kirim, S; Sert, M; Tetiker, T | 1 |
| Guzelmeric, K; Seker, N; Turan, C; Unal, O | 1 |
| Al-Inany, H | 2 |
| Inal, MM; Taner, CE; Yildirim, Y | 1 |
| Catania, VA; Ikushiro, S; Luquita, MG; Mottino, AD; Ruiz, ML; Villanueva, SS | 1 |
| Ciurea, A; Krunic, A; Scheman, A | 1 |
| Yildiz, BO | 1 |
| Aral, Y; Bavbek, N; Culha, C; Demirbas, B; Güler, S; Karakurt, F; Sahin, I; Serter, R | 1 |
| Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
| Alacacioglu, A; Bilgir, O; Kebapcilar, AG; Kebapcilar, L; Kozaci, DL; Sari, I; Taner, CE; Yildiz, Y; Yuksel, A | 1 |
| Gul, S; Kelekci, KH; Kelekci, S; Yengel, I; Yilmaz, B | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
| Lages, L; Maier, PS; Mattiello, SS; Spritzer, PM | 1 |
| de Sá, MF; dos Reis, RM; Fernandes, JB; Ferriani, RA; Martins, WP; Soares, GM; Vieira, CS | 1 |
| Bayraktar, M; Cinar, N; Harmanci, A; Yildiz, BO | 1 |
| Maier, PS; Spritzer, PM | 1 |
| Dixit, S; Fischer, G; Olsson, A | 1 |
| Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
| Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
| Defreyne, J; T'Sjoen, G | 1 |
| Fung, R; Lega, I | 1 |
| de Zegher, F; Del Río, L; Díaz, M; Ibáñez, L; López-Bermejo, A; Pozo, ÓJ; Sebastiani, G | 1 |
| Badmus, OO; Olatunji, LA | 1 |
| Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
5 review(s) available for spironolactone and ethinyl estradiol
| Article | Year |
|---|---|
Update and future of hormonal therapy in acne.
Topics: Acne Vulgaris; Androgen Antagonists; Androgens; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone; Estradiol Congeners; Ethinyl Estradiol; Glucocorticoids; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Sebum; Spironolactone | 2003 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
18 trial(s) available for spironolactone and ethinyl estradiol
| Article | Year |
|---|---|
Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone.
Topics: Analysis of Variance; Androstane-3,17-diol; Blood Pressure; Body Weight; Cholesterol, HDL; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Norethindrone; Spironolactone; Testosterone | 1991 |
Antiandrogens and hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hydroxyprogesterones; Prolactin; Spironolactone; Testosterone | 1987 |
Antiandrogens in the treatment of acne and hirsutism.
Topics: Acne Vulgaris; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Progestins; Spironolactone; Structure-Activity Relationship; Testosterone | 1983 |
Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Prospective Studies; Single-Blind Method; Spironolactone; Testosterone | 1996 |
Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Hormones; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies; Spironolactone; Treatment Outcome | 1998 |
Spironolactone as a single agent for long-term therapy of hirsute patients.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenedione; Cyproterone Acetate; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Testosterone | 2000 |
The effect of combined oral contraception with or without spironolactone on bone mineral density of hyperandrogenic women.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcium; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Luteinizing Hormone; Osteocalcin; Phosphates; Spironolactone | 2000 |
Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Spironolactone; Testosterone | 2003 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Lipids; Prospective Studies; Spironolactone; Young Adult | 2008 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients.
Topics: Adolescent; Adult; CD40 Antigens; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Young Adult | 2010 |
Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Severity of Illness Index; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2012 |
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Aldo-Keto Reductase Family 1 Member C3; Brazil; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Genetic Association Studies; Hirsutism; Humans; Hydroxyprostaglandin Dehydrogenases; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Young Adult | 2012 |
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Triglycerides; Vasodilation | 2012 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome.
Topics: Adolescent; Body Mass Index; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Intra-Abdominal Fat; Levonorgestrel; Metformin; Oligomenorrhea; Ovulation; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Thiazolidinediones | 2017 |
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
38 other study(ies) available for spironolactone and ethinyl estradiol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
Topics: Benzhydryl Compounds; Binding Sites; Diethylstilbestrol; Endocrine System; Hydrocarbons, Chlorinated; Ligands; Models, Molecular; Molecular Conformation; Phenols; Phytoestrogens; Quantitative Structure-Activity Relationship; Receptors, Androgen; Testosterone; Thermodynamics; Xenobiotics | 2005 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Screening for anti-hormones by receptor studies.
Topics: Androgen Antagonists; Animals; Anura; Cricetinae; Cytosol; Estrenes; Estrogen Antagonists; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Kidney; Male; Mice; Mineralocorticoid Receptor Antagonists; Norgestrienone; Progesterone; Prostate; Rats; Receptors, Cell Surface; Spironolactone; Uterus | 1975 |
The effect of enzyme induction on the irreversible binding of ethynyloestradiol to guinea pig liver microsomes.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Cytochrome Reductases; Enzyme Induction; Ethinyl Estradiol; Flavonoids; Guinea Pigs; In Vitro Techniques; Male; Microsomes, Liver; Phenobarbital; Rifampin; Spironolactone | 1978 |
Therapeutic alternatives for the hirsute woman.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Retrospective Studies; Spironolactone; Trinidad and Tobago | 1992 |
Role of liver plasma membrane fluidity in the pathogenesis of estrogen-induced cholestasis.
Topics: Animals; Bile; Cholestasis; Ethinyl Estradiol; Fluorescence Polarization; Liver; Male; Membrane Fluidity; Membrane Lipids; Phospholipids; Rats; Rats, Inbred Strains; Sphingomyelins; Spironolactone; Structure-Activity Relationship | 1988 |
Spironolactone and estrogen-progestin therapy for hirsutism.
Topics: Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Norethindrone; Spironolactone; Testosterone | 1987 |
A comparative study of Aldactone and Diane in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin; Spironolactone | 1987 |
Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.
Topics: Adolescent; Adult; Androstane-3,17-diol; Androstanols; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Female; Hirsutism; Humans; Mestranol; Monitoring, Physiologic; Norethindrone; Prednisone; Spironolactone; Time Factors | 1987 |
Prolonged suppression of hirsutism with combination therapy in an adolescent with insulin resistance and acanthosis nigricans.
Topics: Acanthosis Nigricans; Adolescent; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin Resistance; Norethindrone; Spironolactone; Syndrome | 1987 |
Therapeutic evaluation of spironolactone in Indian women with hirsutism.
Topics: Adolescent; Adult; Drug Therapy, Combination; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hirsutism; Humans; India; Norgestrel; Spironolactone | 1986 |
Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Hirsutism; Humans; Spironolactone | 1985 |
[Budd-Chiari syndrome after taking contraceptive drugs].
Topics: Adult; Ascites; Budd-Chiari Syndrome; Contraceptives, Oral; Coumarins; Ethinyl Estradiol; Female; Heparin; Hepatomegaly; Humans; Norgestrel; Spironolactone | 1972 |
Adsorption of organic compounds by commercial filter papers and its implication on quantitative--qualitative chemical analysis.
Topics: Adsorption; Chemistry Techniques, Analytical; Ethinyl Estradiol; Filtration; Griseofulvin; Naphthalenes; Paper; Solubility; Spironolactone; Warfarin; Water | 1970 |
[Diagnosis and treatment of hirsutism].
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Spironolactone | 1984 |
Hirsutism and problem of its management.
Topics: Adolescent; Adult; Allylestrenol; Dexamethasone; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Progesterone; Retrospective Studies; Spironolactone | 1982 |
Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
Topics: Acanthosis Nigricans; Adolescent; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Insulin Resistance; Remission Induction; Spironolactone; Syndrome | 1997 |
Augmentation mammaplasty in male-to-female transsexuals.
Topics: Adult; Androgen Antagonists; Breast; Breast Implantation; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Male; Mammaplasty; Middle Aged; Mineralocorticoid Receptor Antagonists; Spironolactone; Transsexualism | 1999 |
Diane 35 and spironolactone combination in the treatment of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone | 2001 |
High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Biomarkers; Body Mass Index; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Norpregnenes; Prostate-Specific Antigen; Spironolactone; Testosterone | 2004 |
Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
Topics: Acetaminophen; Animals; Anion Transport Proteins; Antiporters; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile; Blotting, Western; Cholestasis, Intrahepatic; Ethinyl Estradiol; Gene Expression; Glucuronosyltransferase; Glutathione; Liver; Male; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; SLC4A Proteins; Spironolactone; Up-Regulation | 2007 |
Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Topics: Acne Vulgaris; Adult; Androgen Receptor Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Prospective Studies; Spironolactone; Treatment Outcome | 2008 |
Assessment, diagnosis and treatment of a patient with hirsutism.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone; Ultrasonography | 2008 |
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome.
Topics: Adult; Androstenes; C-Reactive Protein; Cholesterol, HDL; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Polycystic Ovary Syndrome; Prospective Studies; Reproductive Control Agents; Spironolactone; Testosterone; Triglycerides; Young Adult | 2013 |
Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Topics: Adult; Androgens; Anovulation; Aromatase; Blood Pressure; Body Mass Index; Contraceptives, Oral; Ethinyl Estradiol; Female; Gene Frequency; Genotype; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Phenotype; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Spironolactone; Young Adult | 2012 |
A case series of 11 patients with hormone-responsive sebaceous adenitis of the labia minora.
Topics: Adolescent; Adult; Androgen Antagonists; Anti-Bacterial Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Inflammation; Middle Aged; Sebaceous Gland Diseases; Spironolactone; Tetracyclines; Vulvar Diseases | 2014 |
Concerning the Article by Fung et al, Titled "Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Prolactin; Spironolactone; Transgender Persons | 2017 |
Response to "Letter to the Editor Concerning the Paper by Fung et al titled 'Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women".
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Prolactin; Spironolactone; Transgender Persons | 2017 |
Involvement of glucocorticoid and mineralocorticoid receptors in lipid accumulation and depressed G6PD activity in the livers of rats treated with postpartum oral estrogen-progestin.
Topics: Animals; Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Glucose; Glucosephosphate Dehydrogenase; Levonorgestrel; Lipid Metabolism; Liver; Mifepristone; Mineralocorticoid Receptor Antagonists; Pregnancy; Progestins; Rats; Rats, Wistar; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Spironolactone | 2019 |